Healthcare
Praxsyn Corporation(PXYN)
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- โ
- Revenue Growth
- -90.1%
- EPS Growth
- +83.3%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Praxsyn Corporation (PXYN) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -90.1%, EPS growth of +83.3%, a dividend yield of 0.0%. What stands out right now is revenue -90.1%, EPS +83.3%, free cash flow 0.0% with operating margin -240.9% and ROIC -4.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PXYN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-90.1% vs +7.6% peer median
Operating Margin
Below sector median
-240.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2019 was reported on Mar 5, 2019, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -90.1% and EPS is at +83.3%, with operating margin around -240.9%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PXYN
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PXYN Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PXYN and SPY.
Company Overview
Praxsyn Corporation
Other OTC
Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers' compensation system, as well as preferred provider contracts. The company was formerly known as The PAWS Pet Company, Inc. and changed its name to Praxsyn Corporation in March 2014. Praxsyn Corporation was founded in 2005 and is headquartered in Las Vegas, Nevada.
- Leadership
- Sean Daly
- IPO Date
- Aug 16, 2010
- Employees
- 66
- Street Address
- 61 Spectrum
- Mailing
- Las Vegas, IL
- Region
- Las Vegas, IL, US
- Reporting Currency
- USD
- Investor Line
- +1 949 777 6112
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.1
- Price/Book
- 0.0
Growth
- Revenue
- -90.1%
- EPS
- +83.3%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 29.4%
- Operating Margin
- -240.9%
- Net Margin
- -695.5%
- ROE
- -20.2%
- ROIC
- -4.7%
Balance Sheet
- Debt/Equity
- 0.65
- Current Ratio
- 1.28
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.